Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation

Abstract

The antiplatelet agent clopidogrel has beneficial effects in patients with acute coronary syndromes without ST-segment elevation. However, the risk of major bleeding is increased among patients treated with clopidogrel.

Keywords

MedicineClopidogrelAspirinPlaceboInternal medicineMyocardial infarctionRelative riskStroke (engine)Acute coronary syndromeConfidence intervalCardiologyAnesthesiaSurgery

Related Publications

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

Håkan Emanuelsson , Claes Held , Jay Horrow +13 more

In patients who have an acute coronary syndrome with or without ST-segment elevation, treatment with ticagrelor as compared with clopidogrel significantly reduced the rate of de...

2009 New England Journal of Medicine 6927 citations

Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes

The PURSUIT trial investigators

Inhibition of platelet aggregation with eptifibatide reduced the incidence of the composite end point of death or nonfatal myocardial infarction in patients with acute coronary ...

1998 New England Journal of Medicine 1435 citations

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

Stephen D. Wiviott , Eugene Braunwald , Carolyn H. McCabe +11 more

In patients with acute coronary syndromes with scheduled percutaneous coronary intervention, prasugrel therapy was associated with significantly reduced rates of ischemic events...

2007 New England Journal of Medicine 6636 citations

Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome

Keith A.A. Fox , Shamir R. Mehta , Ron J.G. Peters +4 more

Background— Antiplatelet therapy and antithrombin therapy have been demonstrated to reduce the risk of cardiac events in patients presenting with acute coronary syndrome, yet al...

2004 Circulation 831 citations

Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

John H. Alexander , Renato D. Lópes , Stefan James +31 more

The addition of apixaban, at a dose of 5 mg twice daily, to antiplatelet therapy in high-risk patients after an acute coronary syndrome increased the number of major bleeding ev...

2011 New England Journal of Medicine 990 citations

Publication Info

Year: 2001
Type: article
Volume: 345
Issue: 7
Pages: 494-502
Citations: 6436
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

6436

OpenAlex

Cite This

APA Style

                            
                                
                                    Salim Yusuf, 
                                
                                    Fei-Li Zhao, 
                                
                                    Shaesta Mehta
                                
                                et al.
                            
                            (2001). 
                            Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation. 
                            New England Journal of Medicine
                            , 345
                            (7)
                            , 494-502.
                            https://doi.org/10.1056/nejmoa010746
                        

Identifiers

DOI: 10.1056/nejmoa010746